Loading...
Phase I trial evaluating MEK inhibitor selumetinib with concomitant thoracic radiotherapy in non-small-cell lung cancer
Haslett, Kate Blackhall, Fiona H Koh, P Ashcroft, Linda Asselin, M Dive, Caroline Harris, C Jackson, Alan Manoharan, Prakash Mullan, Damian
Haslett, Kate
Blackhall, Fiona H
Koh, P
Ashcroft, Linda
Asselin, M
Dive, Caroline
Harris, C
Jackson, Alan
Manoharan, Prakash
Mullan, Damian
Citations
Altmetric:
Abstract
Description
Date
2018-01
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Phase I trial evaluating MEK inhibitor selumetinib with concomitant thoracic radiotherapy in non-small-cell lung cancer 2018, 115:S65 Lung Cancer